Febrile Seizures

Febrile seizures (FS) are the commonest seizure disorder of childhood and a perennial favourite of NEET PG examiners because the line between a benign self-limited event and an ominous CNS infection is drawn entirely on clinical grounds. These notes cover the precise definitions, the simple-versus-complex divide, work-up rationale, acute and prophylactic management, recurrence and epilepsy risk, and the parental counselling points that frequently appear as single-best-answer stems.

Definition

A febrile seizure is a seizure occurring in a child between 6 months and 5 years (60 months) of age, in association with fever (≥ 38°C / 100.4°F), in the absence of CNS infection, intracranial pathology, metabolic derangement, or a prior history of afebrile seizures (i.e. not established epilepsy).

Key qualifiers built into the definition:

• The seizure is provoked by fever from an extracranial source (commonly viral URTI, otitis media, roseola/HHV-6, post-immunisation fever).
• It must not be caused by meningitis, encephalitis, or a metabolic cause such as hypoglycaemia, hyponatraemia, or hypocalcaemia. If those are present, it is a symptomatic/provoked seizure, not a febrile seizure.
• A neonate (< 1 month) or a child > 5 years having a fever-associated seizure does not fit the classic definition and demands a search for another cause.

High-yield: The single most important task when a child presents with a "seizure plus fever" is to exclude CNS infection (meningitis/encephalitis). A febrile seizure is fundamentally a diagnosis of exclusion.

The peak incidence is around 18 months, and the overall prevalence is 2–5% of children. There is a strong genetic predisposition (autosomal dominant with reduced penetrance / polygenic; positive family history in ~25–40%). Genes implicated include SCN1A, SCN1B, and GABRG2; severe end of the spectrum overlaps with GEFS+ (Generalised Epilepsy with Febrile Seizures plus) and Dravet syndrome (SCN1A).

Classification — Simple vs Complex

This dichotomy is the most tested concept. A febrile seizure is complex if it has any one of three features; if it has none, it is simple.

Feature	Simple FS	Complex FS
Seizure type	Generalised (tonic-clonic, tonic, atonic)	Focal / partial (or focal onset)
Duration	< 15 minutes	≥ 15 minutes (prolonged)
Recurrence within 24 h / same illness	Single seizure in 24 h	≥ 2 seizures in 24 h
Post-ictal neuro deficit	None	May have transient focal deficit (Todd's palsy)
Proportion of all FS	~65–75%	~25–35%

A fourth entity worth knowing: Febrile status epilepticus = a febrile seizure lasting > 30 minutes (or recurrent seizures without inter-ictal recovery for > 30 min). This is the form most strongly linked to subsequent mesial temporal sclerosis and temporal lobe epilepsy (the FEBSTAT study connection).

High-yield: "Complex" requires only ONE of — focal, prolonged (≥ 15 min), or multiple in 24 h. Mnemonic: "FML" → Focal, Multiple (recurrent in 24 h), Long (≥ 15 min).

Etiology & Pathophysiology

• Trigger: It is the rate of rise of temperature, and the height of fever, that matters more than absolute peak. The seizure frequently occurs early in the febrile illness, sometimes as the presenting sign before fever is appreciated.
• Cytokine role: Pyrogenic cytokines, especially interleukin-1β (IL-1β), increase neuronal excitability; IL-1β enhances glutamatergic (NMDA) transmission and reduces GABAergic inhibition. Polymorphisms in the IL-1 system are associated with FS susceptibility.
• Immature brain: The developing brain (6 months–5 years) has a lower seizure threshold; respiratory alkalosis from fever-induced hyperventilation may further raise neuronal excitability.
• Common infective triggers: HHV-6 (roseola infantum) is classically associated, as are influenza A, and viral URTIs. Post-vaccination FS is recognised with MMR (peak 8–14 days, the live measles component) and DTP/whole-cell pertussis (within 24–48 h). The absolute risk after vaccination remains very low and does not contraindicate immunisation.

Clinical Features

• Typically a generalised tonic-clonic seizure: sudden loss of consciousness, stiffening then rhythmic jerking, uprolling of eyes, possible cyanosis, frothing, and incontinence.
• Most simple FS are brief (1–3 min) and self-terminate before reaching hospital.
• A short post-ictal drowsiness is expected; prolonged altered sensorium, persistent focal deficit, or a bulging fontanelle should redirect you toward CNS infection.
• The child is otherwise developmentally normal with a normal inter-ictal neurological examination.

Red flags that argue AGAINST a simple febrile seizure (look for the alternative diagnosis):

High-yield: Bulging/tense fontanelle, neck stiffness/meningism, petechial rash, persistent depressed sensorium, focal neurological deficit, age < 6 months or > 5 years, or a child who is toxic/lethargic — all mandate active exclusion of meningitis/encephalitis and a low threshold for lumbar puncture.

Diagnosis & Investigation of Choice

Febrile seizure is a clinical diagnosis. The investigative effort is directed at finding the source of fever and ruling out meningitis, not at "working up the seizure."

Lumbar puncture (LP) — the central decision

Scenario	LP recommendation (AAP-based)
Any child with meningeal signs / clinical suspicion of meningitis	LP strongly recommended
Infant 6–12 months, immunisation (Hib/pneumococcal) incomplete or unknown	Consider LP
Child on antibiotics (may mask meningitis — partially treated)	Consider LP
Simple FS, well-appearing, fully immunised, > 12 months	LP NOT routinely indicated
Complex FS / febrile status	Individualise; lower threshold, esp. if prolonged or focal

High-yield (very frequently asked): In a simple febrile seizure in a well-looking, fully immunised child > 12 months, routine LP, EEG, neuroimaging (CT/MRI), and electrolytes are NOT indicated. The most useful step is to identify and treat the fever source.

Other investigations

• EEG: Not indicated in simple FS. Even in complex FS, EEG done acutely is of limited prognostic value and is not routinely recommended; reserve for atypical features or suspected epilepsy.
• Neuroimaging (CT/MRI): Not for simple FS. Consider MRI in complex FS with focal features, post-ictal focal deficit not resolving, microcephaly, or developmental delay.
• Blood tests: Electrolytes, calcium, magnesium, glucose, CBC are not routine in simple FS — order them only when clinically directed (e.g. dehydration, prolonged seizure, poor feeding, suspected metabolic cause). Capillary glucose should always be checked in any actively seizing child.
• Blood/urine cultures: As guided by the febrile work-up appropriate for age.

Acute Management

Most FS terminate spontaneously before treatment. The approach to the actively seizing child:

Stepwise approach (febrile seizure that does not stop on its own):

1. ABC + position — left lateral, protect airway, suction secretions, give oxygen, do not force anything into the mouth.
2. Check capillary blood glucose; if hypoglycaemic, correct.
3. If seizure persists ≥ 5 minutes → first-line benzodiazepine.

Benzodiazepine choice (first line):

• IV/IO lorazepam 0.1 mg/kg (preferred when access available) OR IV diazepam 0.2–0.3 mg/kg.
• No IV access? → Buccal/intranasal midazolam 0.2–0.3 mg/kg OR rectal diazepam 0.5 mg/kg (classic out-of-hospital option, parent-administered).

If seizure continues (febrile status / refractory):

4. Repeat benzodiazepine once after 5 minutes →
5. Escalate to second-line antiepileptic: IV phenytoin / fosphenytoin (20 mg/kg), levetiracetam (40–60 mg/kg), or valproate →
6. Refractory status → intubation + anaesthetic infusion (midazolam/thiopentone), ICU.

High-yield: First-line drug for an ongoing febrile seizure = a benzodiazepine (lorazepam IV / midazolam buccal-IN / diazepam rectal). Rectal diazepam and buccal midazolam are the standard "rescue" medications parents are taught to give at home for a prolonged event.

Antipyretics (paracetamol/ibuprofen): Give for comfort, but counsel that aggressive antipyretic use does NOT prevent recurrence of febrile seizures — a classic exam misconception to reject.

Prophylaxis — when (and when not) to treat

This is heavily tested because the "correct" answer is usually reassurance, not drugs.

• Continuous (daily) anticonvulsant prophylaxis (phenobarbitone, valproate) is NOT recommended for simple FS. Although they reduce recurrence, the adverse effects (behavioural disturbance, cognitive/hepatic effects) outweigh benefit in a benign condition. AAP explicitly advises against it.
• Intermittent oral clobazam or clobazam/diazepam during febrile episodes can be considered in selected children with frequent or prolonged recurrences / high parental anxiety, but is not routine.
• Antipyretics: comfort only; do not prevent recurrence.

High-yield: For typical simple febrile seizures, the evidence-based management is parental education and reassurance — NO daily prophylactic antiepileptic. The risk of long-term epilepsy is essentially unchanged by prophylaxis.

Recurrence Risk

Roughly 30–35% of children with a first FS will have at least one recurrence; about half of those have a third. The earlier the first seizure, the higher the recurrence.

Major risk factor for recurrence	Effect
Young age at onset (< 12–18 months)	Strongest predictor
Family history of febrile seizures	Increases risk
Low peak temperature at the seizure	Lower threshold → more recurrences
Short duration of fever before seizure (< 1 h)	Increases risk
Family history of epilepsy	Mild increase

Mnemonic for recurrence risk: "FLY" → Family history, Low temperature/short fever, Young age. (Having all four classic factors pushes recurrence toward ~70%.)

Risk of Subsequent Epilepsy

• General population baseline risk of epilepsy ≈ 1%.
• Simple FS: risk of later epilepsy is only marginally higher, about 1–2.5%.
• Complex FS / multiple risk factors: risk rises to 5–10% and higher with combinations.

Risk factor for later epilepsy (different from recurrence factors)
Complex febrile seizure (focal/prolonged/multiple)	Yes
Family history of epilepsy (afebrile)	Yes
Pre-existing neurodevelopmental abnormality / developmental delay	Yes
Short interval between fever onset and seizure	Minor

High-yield: Recurrence of FS and epilepsy are predicted by different sets of factors. Young age + family history of FS → predict recurrence. Complex features + abnormal development + family history of epilepsy → predict later epilepsy. Examiners love to swap these lists.

Febrile Status Epilepticus & Mesial Temporal Sclerosis

Prolonged febrile seizures (febrile status, > 30 min) — especially focal and prolonged — are associated with later development of mesial temporal sclerosis (hippocampal sclerosis) and mesial temporal lobe epilepsy. The FEBSTAT study demonstrated acute hippocampal injury on MRI after prolonged febrile seizures. This is the one situation where neuroimaging (MRI) and follow-up are genuinely warranted.

Complications

• Most simple FS have no long-term sequelae — normal cognition, behaviour, and academic outcomes; no increased mortality.
• Injury during the event (aspiration, trauma) is uncommon.
• Febrile status → risk of mesial temporal sclerosis as above.
• The chief "complication" in practice is parental anxiety ("the child is dying" perception), which good counselling addresses.

Key Differentials

Always consider conditions that mimic FS or that present as "fever + seizure":

• Bacterial meningitis / viral encephalitis (HSV) — the must-exclude diagnosis; look for toxicity, persistent altered sensorium, focal signs, bulging fontanelle.
• Febrile myoclonus / febrile delirium / rigors (shivering) — not true seizures; no loss of consciousness, normal post-ictal state.
• Breath-holding spells — cyanotic/pallid, provoked by crying or minor injury, not fever-driven.
• Metabolic provoked seizures — hypoglycaemia, hyponatraemia (e.g. dilutional from hypotonic fluids/gastroenteritis), hypocalcaemia.
• Dravet syndrome (SMEI) — onset in first year, prolonged hemiclonic febrile seizures, often triggered by fever/vaccination, later refractory epilepsy + developmental regression; due to SCN1A mutation. Sodium channel blockers (carbamazepine, lamotrigine, phenytoin) are CONTRAINDICATED as they worsen seizures.
• GEFS+ — familial syndrome where febrile seizures persist beyond 6 years and coexist with afebrile generalised seizures.
• Shigella gastroenteritis — classically causes seizures (neurotoxin) with fever and diarrhoea.

High-yield: A child with recurrent prolonged hemiclonic febrile seizures in the first year of life, often vaccine/fever triggered, → think Dravet syndrome (SCN1A); avoid carbamazepine/lamotrigine/phenytoin.

Parental Counselling (frequently a stem)

Counselling points that double as exam facts:

1. Febrile seizures are common and benign; they do not cause brain damage, intellectual disability, or death in their simple form.
2. Recurrence can occur (~1 in 3), highest in the first year after the event.
3. Risk of developing epilepsy is only slightly above the general population for simple FS.
4. First aid: place the child on their side, clear the area, time the seizure, do not put fingers/spoon/water in the mouth, do not restrain.
5. Seek emergency care / give rescue medication if the seizure lasts > 5 minutes, if breathing is difficult, if it is the first seizure, or if recovery is delayed.
6. Antipyretics improve comfort but do not prevent recurrence.
7. Immunisations should continue as scheduled — FS is not a contraindication.

Recently asked / exam angle

• "All are true about simple febrile seizure EXCEPT…" → answer is usually the option claiming LP/EEG/CT is routinely required or that daily prophylaxis prevents epilepsy.
• Define complex FS → expect focal OR > 15 min OR > 1 in 24 h (any one).
• Peak age / age range → 6 months to 5 years, peak ~18 months.
• First-line acute drug → benzodiazepine (rectal diazepam / buccal midazolam in pre-hospital setting; IV lorazepam in hospital).
• Strongest recurrence predictor → young age at first seizure.
• Virus classically associated → HHV-6 (roseola).
• Prolonged febrile seizure later linked to → mesial temporal sclerosis (FEBSTAT).
• Vaccine timing: MMR febrile seizure at 8–14 days; DTP within 1–2 days.
• Cytokine implicated → IL-1β.
• Antipyretics → do NOT reduce recurrence (common "EXCEPT" trap).

Rapid revision

1. Febrile seizure = seizure + fever, age 6 months–5 years, no CNS infection/metabolic cause, no prior afebrile seizure.
2. Simple = generalised, < 15 min, single in 24 h; Complex = focal OR ≥ 15 min OR ≥ 2 in 24 h (any one).
3. Peak age ~18 months; prevalence 2–5%; strong genetic basis (SCN1A, GABRG2).
4. Simple FS in a well, immunised child > 12 months → no LP, no EEG, no CT/MRI, no electrolytes routinely.
5. Exclude meningitis above all; LP if meningeal signs, age 6–12 m with incomplete Hib/pneumococcal vaccination, or on antibiotics.
6. Acute drug of choice = benzodiazepine: IV lorazepam / buccal midazolam / rectal diazepam.
7. No daily antiepileptic prophylaxis for simple FS; intermittent clobazam only in select cases.
8. Antipyretics give comfort but do NOT prevent recurrence.
9. Recurrence (~30–35%) predicted by young age, family history of FS, low fever peak, short pre-seizure fever.
10. Later epilepsy predicted by complex FS, abnormal development, family history of epilepsy — overall risk only ~1–2% for simple FS.
11. Febrile status (> 30 min) → risk of mesial temporal sclerosis (FEBSTAT); warrants MRI/follow-up.
12. Recurrent prolonged hemiclonic febrile seizures in infancy + regression → Dravet syndrome (SCN1A); avoid carbamazepine/lamotrigine/phenytoin. Continue routine immunisation.